Passage Bio Inc reports results for the quarter ended in September - Earnings Summary

Passage Bio

10/11/2022 14:33

* Passage Bio Inc  PASG.OQ  reported a quarterly adjusted
loss
of 49 cents​​ per share for the quarter ended in September. The
mean expectation of nine analysts for the quarter was for a loss
of 79 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Passage Bio Inc's reported EPS for the quarter was a loss
of 49
cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Passage Bio Inc shares had fallen by 4.0% this quarter and
lost 81.1% so far this year.
    * The company reported a quarterly loss of $26.7 million.
    * Wall Street's median 12-month price target for Passage Bio
Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.79          -0.49          Beat
 Jun. 30 2022      -0.83          -0.73          Beat
 Mar. 31 2022      -0.89          -0.79          Beat
 Dec. 31 2021      -0.89          -0.95          Missed